BioAge Labs
BIOA
NASDAQ
IPO2024
about BIOA
BioAge Labs specializes in biotechnology research focused on developing innovative solutions to address age-related diseases and enhance human longevity through therapeutic discovery and diagnostic platforms.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $16.14 | $16.43 | $14.63 | $552.53M | 1.51M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.56 | n/a | 262.68 | -1126.58% | -982.04% | 0% |